» Articles » PMID: 10052477

Association of Methylenetetrahydrofolate Reductase Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes?

Overview
Date 1999 Mar 3
PMID 10052477
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Methylenetetrahydrofolate reductase genetic polymorphism and the risk of diabetic nephropathy in type 2 diabetic patients.

Guan H, Xia M, Wang M, Guan Y, Lyu X Medicine (Baltimore). 2020; 99(35):e21558.

PMID: 32871871 PMC: 7458257. DOI: 10.1097/MD.0000000000021558.


Association of MTHFR C677T polymorphism and type 2 diabetes mellitus (T2DM) susceptibility.

Meng Y, Liu X, Ma K, Zhang L, Lu M, Zhao M Mol Genet Genomic Med. 2019; 7(12):e1020.

PMID: 31663297 PMC: 6900375. DOI: 10.1002/mgg3.1020.


Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach.

Huang T, Ren J, Huang J, Li D BMC Genomics. 2013; 14:867.

PMID: 24320691 PMC: 3878883. DOI: 10.1186/1471-2164-14-867.


Methylenetetrahydrofolate reductase gene polymorphism and risk of type 2 diabetes mellitus.

Zhong J, Rodriguez A, Yang N, Li L PLoS One. 2013; 8(9):e74521.

PMID: 24023947 PMC: 3762795. DOI: 10.1371/journal.pone.0074521.


Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis.

Zintzaras E, Uhlig K, Koukoulis G, Papathanasiou A, Stefanidis I J Hum Genet. 2007; 52(11):881-890.

PMID: 17805475 DOI: 10.1007/s10038-007-0189-3.